Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,150 | -77,187 | -38,924 | -36,957 | -37,177 |
| Depreciation Amortization | 2,760 | 1,930 | 733 | 1,093 | 434 |
| Income taxes - deferred | 1,438 | -775 | -658 | N/A | N/A |
| Accounts receivable | 4,329 | -2,168 | -2,771 | -1,816 | N/A |
| Accounts payable and accrued liabilities | 1,780 | -2,799 | 5,491 | 91 | -115 |
| Other Working Capital | -19,016 | 26,144 | -18,017 | 35,557 | -112 |
| Other Operating Activity | 2,375 | 13,328 | 4,199 | 5,904 | 6,998 |
| Operating Cash Flow | $-72,484 | $-41,527 | $-49,947 | $3,872 | $-29,972 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -471 | -967 | -486 | -666 | -347 |
| Purchase Of Investment | -280,027 | -166,936 | -71,060 | -39,546 | -73,169 |
| Sale Of Investment | 189,533 | 114,193 | 73,759 | 56,035 | 14,188 |
| Investing Cash Flow | $-90,965 | $-53,710 | $2,213 | $15,823 | $-59,328 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -14 | 9,765 | N/A | N/A | N/A |
| Debt Repayment | -10,524 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 258,164 | 36,271 | 24,115 | 65,554 | 83,799 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 22,508 |
| Financing Cash Flow | $247,626 | $46,036 | $24,115 | $65,554 | $106,307 |
| Exchange Rate Effect | 175 | -26 | -177 | 146 | 22 |
| Beginning Cash Position | 33,466 | 82,693 | 106,489 | 21,094 | 4,065 |
| End Cash Position | 117,818 | 33,466 | 82,693 | 106,489 | 21,094 |
| Net Cash Flow | $84,352 | $-49,227 | $-23,796 | $85,395 | $17,029 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,484 | -41,527 | -49,947 | 3,872 | -29,972 |
| Capital Expenditure | -471 | -967 | -486 | N/A | -347 |
| Free Cash Flow | -72,955 | -42,494 | -50,433 | 3,872 | -30,319 |